H.R. 3595 amends federal law to allow doctors and pharmacies to share patient records about substance use disorder medications (like methadone and buprenorphine) with state prescription drug monitoring programs, provided that state law requires such sharing. This bill affects healthcare providers, patients receiving addiction treatment, and state health agencies. The legislation removes a federal privacy barrier that previously prevented this information from being reported to state monitoring systems, enabling states to better track and prevent prescription drug misuse in their jurisdiction. There is no specific funding or implementation timeline mentioned in the legislation; the change would take effect once the bill is enacted and state laws are adjusted as needed.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.